Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 876 results for "roche"

Roche therapy helps 24 percent of untreated bladder cancer patients: study

Roche Receives FDA Approval for Novel PD-L1 Biomarker Assay

Roche today announced approval of the VENTANA PD-L1 (SP142) Assay1 by the US Food and Drug Administration (FDA) as a complementary diagnostic to provide PD-L1 status on patients who are considering treatment with the FDA approved Roche immunotherapy ... Infrosoft, 8 hours ago
Roche demands urgent re-assessment of cancer drug approvals in UK Pharmaceutical Technology, 14 hours ago

2,391 images for roche

American Banking News - Forex, 2 days ago
Irish Times, 1 day ago
The Irish News, 3 days ago
Octafinance, 2 days ago, 3 days ago, 4 days ago
Pharmafile, 22 hours ago
AOL UK, 4 days ago
Ticker Report, 1 week ago
Mortgage Servicing News, 3 hours ago

New Cancer Drugs Fund is flawed without NICE reform, says Roche

Nigel Hawkes London The drug company Roche has called for a review of how the National Institute for Health and Care Excellence (NICE) approves drugs for use on the NHS after the launch of the revamped Cancer Drugs Fund, which it says will ...
 British Medical Journal14 hours ago Roche urges reform of Cancer Drugs Fund as NICE takes control  Pharmafile22 hours ago Cancer Drugs Fund Revamp Means Drugmakers Shoulder Overspending  FirstWord Pharma8 hours ago Working to overhaul CDF, NICE faces new calls for reform  FiercePharma16 hours ago

Roche Quietly Takes Hemophilia Lead

While the excitement in hemophilia treatment has been all about the once-and-done approach of gene therapy, Roche ( OTCQX:RHHBY ) has in its own unspectacular way advanced an antibody now forecast to be one of only two blockbusters in the space in ...
 Seeking Alpha15 hours ago Roche quietly takes haemophilia lead  CPhI.cn1 day ago

Vemurafenib Shows Activity in Refractory Thyroid Cancer

Vemurafenib ( Zelboraf , Roche/Genentech), a BRAF inhibitor marketed for use in the treatment of melanoma, has now shown activity in patients with refractory papillary thyroid cancer. For the approximately 25% to 50% of patients with unresectable ...
 Dermatology Online Journal15 hours ago
Pharma Letter

ROCHE : Spatial passing Roche

Spatial passing Roche more info : Location : FRANCE BidDate : 9/1/2016 Tender Country : FRANCE Tender Type : Tenders Tendering Authority : Town marennes Tendering Authority Address : Address: 6 Avenue Marechal Foch17320Marennes Financier : Self ...
 4 Traders1 hour ago ROCHE : Township adopts roche phase 1 redevelopment plan  4 Traders1 day ago Roche delivers continued growth in the first half of 2016  World Pharma News3 days ago Roche reports solid sales growth in the first half of 2016  Doing Business.ro4 days ago
Mr Top Step

BRIEF-AbbVie initiates late stage study of venetoclax in patients with relapsed or refractory multiple myeloma

July 28 Abbvie Inc * Venetoclax is being developed by abbvie and genentech, a member of roche group * Abbvie announces initiation of phase 3 study of venetoclax in patients with relapsed or refractory multiple myeloma Source text for Eikon: ...
 Reuters UK1 day ago AbbVie Reports SecondQuarter 2016 Financial Results  Pharma Focus Asia55 minutes ago What's in Store for Prothena (PRTA) This Earnings Season?  Mr Top Step1 hour ago HC Stocks News Alerts: AbbVie Inc (NYSE:ABBV), OraSure Technologies, Inc. (NASDAQ:OSUR)  Share Market Updates17 hours ago

Dan Martin and Nicolas Roche to assess form in San Sebastián

Irish duo in final preparations for Rio Olympic games medals attempt Theyve had a very different buildup towards the Olympic Games but first cousins Dan Martin and Nicolas Roche will both have a chance to test their form in this weekend's Clásica ...
 Irish Times1 day ago

Roche's hemophilia candidate emicizumab shows encouraging results in early-stage study

Long-term follow-up data from a 16-subject Phase 1/2 clinical trial assessing Roche's ( OTCQX:RHHBY ) investigational biologic emicizumab in patients with severe hemophilia A show encouraging safety and prophylactic efficacy regardless of the ...
 Seeking Alpha1 day ago Roche : emicizumab continued to show promising safety and efficacy profile in long-term study in people with severe haemophilia A  4 Traders2 days ago

BRIEF-Roche CEO says very optimistic about u.s. market

July 21 Roche Holding AG * Ceo says still very optimistic about u.s. Market, discussion about pricing was triggered by older generic drugs in smaller markets Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom) ...
 Reuters UK1 week ago BRIEF-Roche says biotech valuations high, big acquisitions unlikely  Reuters UK1 week ago BRIEF-Roche CEO says Brexit impact is limited  Reuters UK1 week ago

3 - ROCHE KEVIN H (0001024356) (Reporting)

Form 3 - Initial statement of beneficial ownership of securities SEC Accession No. 0001437749-16-035785 Filing Date 2016-07-27 2016-07-27 18:41:01 Period of Report 2016-07-27 Filing Date Changed 2016-07-27 Document Format Files ...
 SEC Filings2 days ago 4 - ROCHE KEVIN H (0001024356) (Reporting)  SEC Filings9 hours ago 3/A - ROCHE KEVIN H (0001024356) (Reporting)  SEC Filings9 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - roche
Get updated on latest news & your favorite topics right in your inbox!
More     Less